These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 9247390)

  • 1. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.
    Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
    Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.
    Pietrini P; Alexander GE; Furey ML; Dani A; Mentis MJ; Horwitz B; Guazzelli M; Shapiro MB; Rapoport SI
    J Nucl Med; 2000 Apr; 41(4):575-83. PubMed ID: 10768555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
    Cutler NR; Heston LL; Davies P; Haxby JV; Schapiro MB
    Ann Intern Med; 1985 Oct; 103(4):566-78. PubMed ID: 2864010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography.
    Rumsey JM; Duara R; Grady C; Rapoport JL; Margolin RA; Rapoport SI; Cutler NR
    Arch Gen Psychiatry; 1985 May; 42(5):448-55. PubMed ID: 3872650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in Alzheimer's disease.
    Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
    Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral metabolic pattern in young adult Down's syndrome subjects: altered intercorrelations between regional rates of glucose utilization.
    Horwitz B; Schapiro MB; Grady CL; Rapoport SI
    J Ment Defic Res; 1990 Jun; 34 ( Pt 3)():237-52. PubMed ID: 2143230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):309-21. PubMed ID: 2948218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology.
    Schapiro MB; Ball MJ; Grady CL; Haxby JV; Kaye JA; Rapoport SI
    Neurology; 1988 Jun; 38(6):938-42. PubMed ID: 2966900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
    Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
    J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
    J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia.
    Haier RJ; Alkire MT; White NS; Uncapher MR; Head E; Lott IT; Cotman CW
    Neurology; 2003 Dec; 61(12):1673-9. PubMed ID: 14694028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.